HF
AHPI

HRT Financial’s Allied Healthcare Products AHPI Stock Holding History

HRT Financial’s Portfolio AHPI Stock Details AHPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-15,293
Closed -$24K – 3783
2022
Q2 		$24K Buy
+15,293
New +$34.7K ﹤0.01% 2587

Other funds holding AHPI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $150M AUM 32.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

HRT Financial's AHPI Position: Q3 2022 in Review

HRT Financial sold out of Allied Healthcare Products (AHPI) in Q3 2022, closing a stake of 15,293 shares — an estimated $24K sold.

HRT Financial first reported a position in AHPI in Q2 2022 and held it in 1 quarter. The position peaked at $24K in Q2 2022. 12 funds tracked by Wall St. Rank hold AHPI as of Q3 2022.

  • HRT Financial reported no remaining Allied Healthcare Products position as of Q3 2022 after selling out during the quarter.
  • HRT Financial sold 15,293 Allied Healthcare Products shares in Q3 2022, an estimated $24K.
  • HRT Financial first reported a position in Allied Healthcare Products in Q2 2022 and held it in 1 quarter.
  • HRT Financial's Allied Healthcare Products position peaked at $24K in Q2 2022.
  • 12 funds tracked by Wall St. Rank held Allied Healthcare Products as of Q3 2022.

Based on HRT Financial's 13F filing for Q3 2022, filed 14 Nov 2022.